Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Incidence
The annual incidence of major depressive disorder (MDD) is approximately 3%, and the average duration of an episode of MDD is 30 weeks.
Epidemiology
MDD is a prevalent disorder, with a global point prevalence of approximately 5%. The life-time prevalence rates of MDD in the US and Western European countries are in the range of 10%–20% in the general population.
Pathophysiology
The pathophysiology of MDD remains largely unknown, but several mechanisms have been proposed, e.g., the monoamine hypothesis, which describes MDD as the consequence of a chemical imbalance in brain serotonin, norepinephrine (noradrenaline), and dopamine.
Clinical Findings
Typical symptoms of MDD include depressed mood, lack of pleasure/interest/motivation, fatigue, feelings of guilt/worthlessness, anxiety/nervousness, irritability/anger, difficulty concentrating, insomnia/hypersomnia, loss of libido, change in appetite/weight, and recurring thoughts of death/suicide.
Differential Diagnoses
Common differential diagnoses to MDD are bipolar disorder, psychotic disorders, dementia, substance use disorders, personality disorders, ADHD, anxiety disorders, eating disorders, and various general medical conditions. With the exception of bipolar disorder and psychotic disorders, MDD can also be co-morbid with these conditions.
Treatment Options
First-line treatment options for MDD include psychotherapy and antidepressant medications (e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), monoamine oxidase inhibitors (MAOIs)). Options for severe and/or treatment-resistant MDD are vagal nerve stimulation (VNS), electroconvulsive therapy (ECT), and deep brain stimulation (DBS).
Complications
MDD is associated with an increased risk of a number of medical illnesses, such as hypertension, diabetes, and heart disease, and it worsens the course of these illnesses, leading to increased morbidity and mortality. The most severe complication/outcome of MDD is suicide.
Prognosis
Most episodes of MDD remit. However, the risk of developing further episodes increases progressively with each recurrence, while the recurring episodes tend to become longer and more severe as the number increases.
Depressive disorders, especially major depressive disorder (MDD), are prevalent conditions that are associated with significant suffering, psychosocial impairment, and increased mortality. Despite the availability of numerous effective treatments, these disorders are often under-recognized and under-treated in the community. Several factors contribute to the under-recognition of depressive disorders; these include the stigma of depression itself and the relative lack of systematic ascertainment of depressive symptoms by health care professionals. The public health significance of depression is noteworthy; apart from the direct psychosocial burden, the disorders also heighten the risk of other medical diseases, and increase their associated morbidity and mortality. According to the World Health Organization, MDD ranks among the leading global burdens of disease.
Patients who suffer from depressive disorders typically have a constellation of psychological, cognitive, behavioral, and physical symptoms. In the case of MDD, depressed mood and loss of interest/pleasure are considered to be the core features of the condition. Both can be present at the same time, but one of them is sufficient to define MDD, if certain associated symptoms are present. Specifically, the Diagnostic and Statistical Manual of Mental Disorders , ed 5 (DSM-5) defines MDD as depressive mood (or irritable mood in children and adolescents) and/or loss of interest/pleasure, accompanied by at least four (only three if both depressed mood and loss of interest/pleasure are present) other depressive symptoms, lasting for at least 2 weeks. The accompanying symptoms (captured in the mnemonic SIG: E CAPS, a prescription for energy capsules) are insomnia/hypersomnia (S), reduced interest/pleasure (I), excessive guilt or feelings of worthlessness (G), reduced energy or fatigue (E), diminished ability to concentrate or make decisions (C), loss or increase of appetite/weight (A), psychomotor agitation/retardation (P), and thoughts of suicide/death or an actual suicide attempt/plan (S). The full DSM-5 diagnostic criteria for MDD are listed in Box 29-1 . The degree of functional impairment is essential to distinguish MDD and the other depressive disorders from normal mood variability. That being said, the continuum of depression from mild, short-lasting, syndromes toward severe, chronic/recurrent and disabling disorders has been repeatedly stressed.
Five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure.
Note: Do not include symptoms that are clearly attributable to another medical condition.
Depressed mood most of the day, nearly every day, as indicated by either subjective report (e.g. feels sad, empty, hopeless) or observation made by others (e.g. appears tearful). ( Note: In children and adolescents, can be irritable mood.)
Markedly diminished interest or pleasure in all, or almost all, activities most of the day, nearly every day (as indicated by either subjective account or observation).
Significant weight loss when not dieting or weight gain (e.g. a change of more than 5% of body weight in a month), or decrease or increase in appetite nearly every day. ( Note: In children consider failure to make expected weight gain.)
Insomnia or hypersomnia nearly every day.
Psychomotor agitation or retardation nearly every day (observable by others, not merely subjective feelings of restlessness or being slowed down).
Fatigue or loss of energy nearly every day.
Feelings of worthlessness or excessive or inappropriate guilt (which may be delusional) nearly every day (either by subjective account or as observed by others).
Diminished ability to think or concentrate, or indecisiveness, nearly every day (either by subjective account or as observed by others).
Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a specific plan, or a suicide attempt or a specific plan for committing suicide.
The symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning.
The episode is not attributable to the physiological effects of a substance or to another medical condition.
Note: Criteria A–C represent a major depressive episode.
Note: Responses to a significant loss (e.g. bereavement, financial ruin, losses from a natural disaster, a serious medical illness or disability) may include the feelings of intense sadness, rumination about the loss, insomnia, poor appetite, and weight loss noted in Criterion A, which may resemble a depressive episode. Although such symptoms may be understandable or considered appropriate to the loss, the presence of a major depressive episode in addition to the normal response to a significant loss should also be carefully considered. This decision inevitable requires the exercise of clinical judgment based on the individual's history and the cultural norms for the expression of distress in the context of loss. 1
1 In distinguishing grief from a major depressive episode (MDE), it is useful to consider that in grief the predominant affect is feelings of emptiness and loss, while in MDE it is persistent depressed mood and the inability to anticipate happiness or pleasure. The dysphoria in grief is likely to decrease in intensity over days to weeks and occurs in waves, the so-called pangs of grief. These waves tend to be associated with thoughts or reminders of the deceased. The depressed mood of MDE is more persistent and not tied to specific thoughts or preoccupations. The pain of grief may be accompanied by positive emotions and humor that are uncharacteristic of the pervasive unhappiness and misery characteristic of MDE. The thought content associated with grief generally features a preoccupation with thoughts and memories of the deceased, rather than the self-critical or pessimistic ruminations seen in MDE. In grief, self-esteem is generally preserved, whereas in MDE feelings of worthlessness and self-loathing are common. If self-derogatory ideation is present in grief, it typically involves perceived failings vis-à-vis the deceased (e.g., not visiting frequently enough, not telling the deceased how much he or she was loved). If a bereaved individual thinks about death and dying, such thoughts are generally focused on the deceased and possibly about “joining” the deceased, whereas in MDE such thoughts are focused on ending one's own life because of feeling worthless, undeserving of life, or unable to cope with the pain of depression.
The occurrence of the major depressive episode is not better explained by schizoaffective disorder, schizophrenia, schizophreniform disorder, delusional disorder, or other specified and unspecified schizophrenia spectrum and other psychotic disorders.
There has never been a manic episode or a hypomanic episode. ( Note: This exclusion does not apply if all of the manic-like or hypomanic-like episodes are substance-induced or are attributable to the physiological effects of another medical condition.)
MDD is a heterogeneous clinical entity. Therefore, in order to allow clinicians and researchers to differentiate patients with distinct clinical presentations, a number of subtypes have been defined.
When patients with depression experience symptoms such as restlessness, tension, excessive worrying or fear of panicking, it is referred to as “anxious depression,” which is a relatively common depressive subtype. Among the depressed patients participating in the multi-center Sequenced Treatment Alternatives to Relieve Depression (STAR*D) project, the prevalence of anxious depression was approximately 45%. Patients with anxious depression tend to have a slower response to treatment and are less likely to respond to antidepressant treatment than are those without anxious depression.
Patients who, in addition to meeting criteria for depression, also display symptoms of elevated mood, grandiosity, pressured speech, racing thoughts, increased energy, risk-taking, and a decreased need for sleep (without meeting full criteria for hypomania or mania) should be assigned the diagnosis of “mixed depression.” These patients are at increased risk of developing bipolar I or bipolar II disorder.
Those with “melancholic depression” are severely depressed patients who are unable to experience pleasure (anhedonia) or who lose normal emotional responsiveness to positive experiences. These patients also exhibit the following characteristics: a distinct quality of depressed mood (despondency, despair, moroseness, or empty mood), a worsening of mood in the morning, excessive/inappropriate guilt, early morning awakening, reduced appetite/weight loss, and psychomotor retardation/agitation.
Atypical depression is characterized by mood reactivity (defined as an ability to temporarily respond to positive experiences) accompanied by rejection sensitivity, hypersomnia, hyperphagia, and prominent physical fatigue (leaden paralysis, with feelings of heaviness in the arms and legs).
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here